Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-07-27

Clinical Trial Update: Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating the efficacy and safety of Lima Association for Type 2 diabetes mellitus was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lima Association (null)

Snippet

Sponsor: EMS | Conditions: Type2 Diabetes Mellitus | Phase 3 | Status: WITHDRAWN